Akzo Unlocks 21x for Southeast Asia Deco While the Market Values the Whole at 8x

A sixth straight quarter of margin expansion, a 5% price take that is denting volumes, and a China recovery quietly pushed beyond 2027 — as the Axalta merger enters the final two divestitures

AKZA.AS · Earnings Call · 2026-10-21

Six quarters of margin, one awkward volume line

AkzoNobel's Q3 was, on the scoreboard, the most boringly good quarter in a long run of them: adjusted EBITDA of EUR 388 million, margin at 15.3%, up 20bps, and the “sixth quarter in a row of margin expansion” — Gregoire Poux-Guillaume, Chief Executive Officer · 2026-10-21. Paints hit a 19.4% margin — 200bps higher — a level CFO Maarten de Vries was careful to frame as unprecedented outside the COVID DIY boom in Europe. Trade working capital came down to 15.7% of revenue, ROIC rose to 13.7%, and leverage sat at 2.1x, already inside the "around 2x" target before a single euro of Asia proceeds has landed. That was delivered on volumes of minus 2%, offset by pricing of plus 5%. The pricing has now run for several quarters and the volume line has not recovered — which makes the elasticity question the only one that really matters, and it drew the only real fight of the call. The CEO's answer was flat: “Pricing doesn't seem to be what's impacting volumes currently” — Gregoire Poux-Guillaume, Chief Executive Officer · 2026-10-21, attributing the softness to phasing of price implementation (weak July-August, stronger September) and to genuinely depressed end markets. Twelve months ago the same management team was reassuring on exactly this point with different words — volumes were "resilient" (“we've not been seeing this” — Maarten de Vries, Chief Financial Officer · 2026-07-22) — and the volume guidance has since downshifted from flat-to-low-single-digit growth to flat for Q4. The volume growth keyword was the company's single biggest momentum gainer back in early 2024, when the debate was about recovery. It is now the quiet narrative risk.

The Deco auction that finally cleared — vindication at 21x

The strategic news is the completion of a two-year Deco portfolio review. Akzo signed a binding agreement to sell its Southeast Asian decorative paints to Nippon Paint for an enterprise value of EUR 1.2 billion — 21x 2025 EBITDA, roughly double where the group trades — with about EUR 900 million of net cash after minorities and taxes, EUR 200 million of it in December (Indonesia) and the balance in mid-2027. All of it goes to deleveraging. The context here is what makes the number sing. In July, management had dismissed Nippon's approach with genuine irritation, calling a ~10x bid for all of Deco “more an intelligence test than it is an offer” — Gregoire Poux-Guillaume, Chief Executive Officer · 2026-07-22. Selling the rump region at 21x, on top of India at ~25x and Pakistan at 14x — over EUR 2.6 billion of enterprise value at a blended 23x — is the cleanest possible rebuttal. It also lands in a market where, as one analyst noted on the call, the pro forma combined multiple is only 7-8x. The multiples gap between private coating assets and public coating equities is now the central fact of the Akzo equity story. That framing has company-specific teeth. Akzo is not simply riding a sector wave; it is monetizing its own non-leadership positions at prices the listed market refuses to capitalize. Southeast Asia has been a live concern since the India disposal and, before that, the Hormuz-era debate over which of these franchises were "more valuable to somebody else." The question now is narrower: management says nothing else in Deco is for sale — "we're not planning to sell anything else in Deco" — leaving Refinish Europe as a forced seller's asset rather than a strategic one, an EU antitrust remedy alongside Axalta's US wood coatings, together worth slightly under EUR 500 million of revenue at roughly the group's target 19-20% margin.

The China sentence that changed

This is where the call diverged from its own archive. In February, management laid out the China Deco script with precision: the market would be down mid-single digits in 2026, Akzo would outperform, and there would be a recovery in 2027. On Wednesday, the recovery was gone from the calendar.

The scenarios we are using also for 2027 is that we don't expect a recovery of that market anytime soon, at least not for '27.
Maarten de Vries, Chief Financial Officer · 2026-10-21

The market, he added, is down roughly 11% this year — closer to double that February call's estimate than to it. For a business that has been the standing "we're gaining share in a depressed market" exhibit for four quarters, quietly deleting the 2027 recovery is a more material disclosure than anything in the EBITDA line.

Costs turn, capital allocation opens, and a data-center tailwind the tape hates

The margin engine is also being asked to work in worse weather. Raw materials ran high-single-digit inflation in Q3, a similar trend is expected in Q4, and the CFO guided a slight further upward drift through H1 2027 before easing in the second half. That is the opposite of the 2025 experience, when the raw material cycle turned into a tailwind and did some of the pricing work for them. Price must now do all of it, and there is a limit to how many more 5% rounds a struggling consumer and a sluggish auto market will absorb. On the positive side, the industrial excellence programme closes out at year-end with four sites already shut, two more to come, and carryover into 2027. Two forward-looking threads deserve more attention than they received. First, data centers: the CEO singled out data-center construction as "a real tailwind" for the Protective business, because these are large, hot structures that need passive fire protection. That is a rare, genuinely new end-market disclosure for Akzo — and it is sharply at odds with the tape, where the global AI data center cluster has been one of the worst-performing theme baskets over both 30 and 90 days, with dozens of decliners and only a handful of advancers. Akzo is selling pickaxes to a construction wave the market has decided is fading. Second, capital allocation: with merger transaction costs already at EUR 69 million year-to-date and free cash flow compressed to EUR 83 million, management nonetheless signalled that deleveraging from the Asia proceeds could restore a normal return policy — and reopened the buyback door, arguing “share buybacks are particularly attractive as long as the market continues not to reflect the value of the merger in our share price” — Gregoire Poux-Guillaume, Chief Executive Officer · 2026-10-21. That is a change of tune from February, when the buyback was simply suspended and the whole return story was one EUR 2.5 billion payment at closing. So the story is not the quarter. The quarter is a tidy, unremarkable execution print. The story is that Akzo has spent two years proving to a skeptical market that its parts are worth far more than the whole — and has now nearly run out of parts to prove it with. What is left is a smaller, sharper paints company merged into Axanzo, guided to close in early 2027 with a $600 million cost-synergy target intact, one EU remedy to sign, and a management team openly telegraphing that the release valve for a depressed share price is buybacks, not another asset sale. For a company with an $8.6 billion market cap and a mid-single-digit earnings multiple, that is a more interesting proposition than a 20bp margin improvement.